Breaking News Instant updates and real-time market news.

AMRN

Amarin

$21.03

-0.26 (-1.22%)

20:10
11/10/18
11/10
20:10
11/10/18
20:10

Amarin to hold an analyst and investor meeting with conference call hookup

Investor and Analyst Meeting to discuss the REDUCE-IT Trial results as presented at the American Heart Association's Scientific Sessions will be held in New York on November 10 at 8:15 pm. Webcast Link

  • 10

    Nov

  • 10

    Nov

  • 10

    Nov

AMRN Amarin
$21.03

-0.26 (-1.22%)

11/08/18
11/08/18
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Stanley Black & Decker (SWK) initiated with a Hold at Deutsche Bank. 2. Comcast (CMCSA) resumed with an Overweight at Morgan Stanley while Amarin (AMRN) and Immunomedics (IMMU) were assumed with a Buy at the firm. 3. Broadcom (AVGO) resumed with a Buy at Deutsche Bank and reinstated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/08/18
JEFF
11/08/18
INITIATION
Target $30
JEFF
Buy
Amarin assumed with a Buy at Jefferies
Jefferies analyst Michael Yee assumed coverage of Amarin with a Buy rating and $30 price target. The analyst sees "semi-high expectations" going into the American Heart Association meeting but he believes investors will come away after the event saying the "data looks good." Further, Amarin is a potential takeover candidate going into 2019 "so the path to least resistance is higher," Yee tells investors in a research note. Based on industry fundamentals Amarin represents "one of only a handful of scarce M&A assets for big pharma and existing pharma metabolic-focused salesforce," says Yee.
11/05/18
RHCO
11/05/18
NO CHANGE
Target $30
RHCO
Buy
Amarin price target raised to $30 from $15 at SunTrust
SunTrust analyst John Boris raised his price target on Amarin to $30 and kept his Buy rating, saying its REDUCE-IT data on Vascepa at the upcoming American Heart Association meeting its expected to show "unprecedented benefits in sub-populations & decrease in hospitalizations". The analyst models the program's sales at $2.5B in 2024 amid a "paradigm shift" in therapy with a long post-loss of exclusivity tail comparable to that of Lovaza.
11/02/18
SBSH
11/02/18
DOWNGRADE
Target $28
SBSH
Neutral
Citi now sees limited upside in Amarin, downgrades to Neutral
Citi analyst Joel Beatty downgraded Amarin to Neutral from Buy while raising his price target for the shares to $28 from $25. The analyst still believe that Vascepa is an attractive drug that will exceed $3B in sales. However, he thinks investor expectations have increased substantially over recent weeks, "such that upside is likely to be limited over the coming months, with the possible exception of an acquisition."

TODAY'S FREE FLY STORIES

PENN

Penn National

$19.76

-0.3 (-1.50%)

06:52
11/14/18
11/14
06:52
11/14/18
06:52
Recommendations
Penn National analyst commentary  »

Penn National added to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$16.82

-0.08 (-0.47%)

06:51
11/14/18
11/14
06:51
11/14/18
06:51
Earnings
Meritor sees FY19 adj. EPS about $3.10, consensus $3.32 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 06

    Dec

  • 13

    Dec

LLY

Eli Lilly

$111.85

-0.77 (-0.68%)

06:51
11/14/18
11/14
06:51
11/14/18
06:51
Hot Stocks
Eli Lilly submits NDA for lasmiditan, gets breakthrough designation for Emgality »

Eli Lilly has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

06:50
11/14/18
11/14
06:50
11/14/18
06:50
General news
European stock markets pared some of their losses »

European stock markets…

GOOS

Canada Goose

$58.60

1.51 (2.64%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Earnings
Canada Goose raises FY19 adj. EPS growth view to at least 25% from at least 40% »

Consensus for FY19 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

SGMO

Sangamo

$10.80

0.8 (8.00%)

, BMRN

BioMarin

$93.51

0.43 (0.46%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Downgrade
Sangamo, BioMarin, Spark Therapeutics rating change  »

JPMorgan downgrades…

SGMO

Sangamo

$10.80

0.8 (8.00%)

BMRN

BioMarin

$93.51

0.43 (0.46%)

ONCE

Spark Therapeutics

$42.74

1.12 (2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MTOR

Meritor

$16.82

-0.08 (-0.47%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Earnings
Meritor reports Q4 adj. EPS 82c, consensus 71c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 06

    Dec

  • 13

    Dec

MRK

Merck

$74.62

-0.06 (-0.08%)

06:48
11/14/18
11/14
06:48
11/14/18
06:48
Hot Stocks
Merck: Phase 3 KEYNOTE-181 trial met a primary endpoint of overall survival »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 11

    Jan

  • 16

    Feb

WFC

Wells Fargo

$52.74

0.38 (0.73%)

06:47
11/14/18
11/14
06:47
11/14/18
06:47
Periodicals
Departure of top Wells Fargo exec Hardison shows rift with regulator, WSJ says »

Hope Hardison, Wells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

TRU

TransUnion

$64.43

-0.41 (-0.63%)

06:47
11/14/18
11/14
06:47
11/14/18
06:47
Hot Stocks
TransUnion CEO James Peck to retire, Chris Cartwright to succeed »

TransUnion announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$58.60

1.51 (2.64%)

06:46
11/14/18
11/14
06:46
11/14/18
06:46
Earnings
Canada Goose reports Q2 adjusted EPS 46c, consensus (7c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

K

Kellogg

$63.48

-0.81 (-1.26%)

, GIS

General Mills

$45.50

-0.2 (-0.44%)

06:46
11/14/18
11/14
06:46
11/14/18
06:46
Downgrade
Kellogg, General Mills, Kraft Heinz rating change  »

JPMorgan downgrades…

K

Kellogg

$63.48

-0.81 (-1.26%)

GIS

General Mills

$45.50

-0.2 (-0.44%)

KHC

Kraft Heinz

$53.38

-0.29 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

06:45
11/14/18
11/14
06:45
11/14/18
06:45
General news
Breaking General news story  »

Week of 11/9 MBA Mortgage…

JNCE

Jounce Therapeutics

$4.40

-0.06 (-1.35%)

06:40
11/14/18
11/14
06:40
11/14/18
06:40
Downgrade
Jounce Therapeutics rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

06:38
11/14/18
11/14
06:38
11/14/18
06:38
Periodicals
Amazon says over 10,000 workers are developing Alexa, Echo, WSJ reports »

Amazon has over 10,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

NOVN

Novan

$2.50

-0.04 (-1.57%)

06:38
11/14/18
11/14
06:38
11/14/18
06:38
Hot Stocks
Novan Phase 2 molluscum contagiosum trial achieves statistical significance »

Novan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

LLESY

Lendlease Group

$0.00

(0.00%)

06:37
11/14/18
11/14
06:37
11/14/18
06:37
Upgrade
Lendlease Group rating change  »

Lendlease Group upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICI

VICI Properties

$21.47

-0.03 (-0.14%)

06:36
11/14/18
11/14
06:36
11/14/18
06:36
Syndicate
VICI Properties files to sell 25M shares of common stock »

Goldman Sachs & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLI

Hollysys

$18.58

-0.37 (-1.95%)

06:36
11/14/18
11/14
06:36
11/14/18
06:36
Earnings
Hollysys reports Q1 adjusted EPS 46c vs. 36c last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ATRO

Astronics

$28.50

-0.13 (-0.45%)

06:35
11/14/18
11/14
06:35
11/14/18
06:35
Earnings
Astronics sees FY19 Aerospace revenue $710M-$745M »

"In our third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

HOLI

Hollysys

$18.58

-0.37 (-1.95%)

06:35
11/14/18
11/14
06:35
11/14/18
06:35
Upgrade
Hollysys rating change  »

Hollysys upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

, GOOGL

Alphabet Class A

$1,048.54

-1.06 (-0.10%)

06:34
11/14/18
11/14
06:34
11/14/18
06:34
Periodicals
Google to double New York City staff over next ten years, WSJ reports »

Google (GOOGL) has plans…

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

GOOGL

Alphabet Class A

$1,048.54

-1.06 (-0.10%)

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

ZYME

Zymeworks

$13.04

-0.2 (-1.51%)

06:33
11/14/18
11/14
06:33
11/14/18
06:33
Hot Stocks
Zymeworks updates clinical data for ZW25 anti-tumor candidate »

Zymeworks presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRO

Astronics

$28.50

-0.13 (-0.45%)

06:33
11/14/18
11/14
06:33
11/14/18
06:33
Hot Stocks
Astronics sells semiconductor test business to Advantest for $185M in cash »

Astronics announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

SNAP

Snap

$6.72

0.06 (0.90%)

, FB

Facebook

$142.19

0.67 (0.47%)

06:32
11/14/18
11/14
06:32
11/14/18
06:32
Periodicals
Snap subpoenaed by DOJ, SEC over IPO disclosures, Reuters reports »

The U.S. Justice…

SNAP

Snap

$6.72

0.06 (0.90%)

FB

Facebook

$142.19

0.67 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.